Exposure-based Treatment for Avoidant Back Pain Patients
- Conditions
- Low Back Pain
- Registration Number
- NCT01484418
- Lead Sponsor
- Philipps University Marburg Medical Center
- Brief Summary
Chronic low back pain often results in psychosocial and physical disability. A subgroup of these patients shows fear of (re)injury and avoidance behaviour leading to higher disability. The purpose of this study is to determine whether exposure in vivo is more effective in the treatment of fear avoidant chronic back pain patients than psychological treatment as usual (cognitive behavioural psychotherapy).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 68
- Having at least 3 months back pain
- Sufficient level on fear avoidance scores (TSK, Phoda)
- Being German-speaking
- Agreeing to participate, verified by completion of informed consent
- Red flags
- Pregnancy
- Illiteracy
- Psychoses
- Alcohol addiction
- surgeries during the last 6 months or planed surgeries
- Specific medical disorders or cardiovascular diseases preventing participation in physical exercise
- Participating in another psychotherapy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change from baseline in pain severity at 3 and 6 months after admission from Pretest (admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission) Numeric Rating Scale (NRS)
Change from baseline in pain disability at 3 and 6 months after admission from Pretest (admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission) Pain Disability Index (PDI) Quebec Back Pain Disability Scale (QBPDS)
- Secondary Outcome Measures
Name Time Method Change in physical activity from Pretest to two in-between timepoints to Posttest to Follow-up Time from Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission) International Physical Activity Questionnaire(IPAQ)
Change in pain catastrophizing from Pretest to two in-between timepoints to Posttest to Follow-up from Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission) Pain Catastrophizing Scale (PCS)
Change in quality of life from Pretest to two in-between timepoints to Posttest to Follow-up from Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission) EuroQol (EQ-5D)
Change in fear avoidance from Pretest to two in-between time points to Posttest from Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission) Tampa Scale of Kinesiophobia (TSK) Pain Anxiety Symptom Scale (PASS)
Change in emotional distress from Pretest to two in-between timepoints to Posttest to Follow-up from Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission) Hospital Anxiety and Depression Scale (HADS)
Trial Locations
- Locations (1)
Philipps University Marburg, Department of Clinical Psychology and Psychotherapy
🇩🇪Marburg, Germany
Philipps University Marburg, Department of Clinical Psychology and Psychotherapy🇩🇪Marburg, Germany